Paragon 28 Inc. is a medical device company headquartered in Englewood, Colorado. The company specializes in the development of innovative foot and ankle devices and surgical techniques for patients suffering from a variety of foot and ankle disorders. Paragon 28 Inc. was founded in 2010 by Albert DaCosta, Jim Edson, and Michael Mcdonald.
The founders of Paragon 28 had previously worked together at another medical device company and decided to start their own venture when they saw a need for new and better solutions in the foot and ankle market. Since its inception, the company has focused on creating high-quality, innovative products that address unmet needs in foot and ankle surgery.
Paragon 28 offers a broad range of products for foot and ankle surgery, including implants, instruments, and biologics. Their products are designed to improve patient outcomes, reduce procedure time, and minimize the risk of complications. Paragon 28's product portfolio includes solutions for deformity correction, reconstruction, and sports medicine.
The company is can be found on the New York Stock exchange under the symbol FNA. The company has experienced rapid growth since its founding and has expanded its operations both domestically and internationally. Paragon 28 products are now available in over 40 countries, and the company has established itself as a leader in the foot and ankle device market.
Paragon 28's commitment to innovation and excellence has been recognized by the medical community, and the company has received numerous awards for its products and technology. The company has also established partnerships with leading medical institutions and surgeons to further advance foot and ankle surgery and improve patient outcomes.